• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. .风湿性多肌痛(PMR)的发病率和患病率:流行病学背景的重要性。
Med Sci (Basel). 2019 Aug 30;7(9):92. doi: 10.3390/medsci7090092.
2
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.巨细胞动脉炎和风湿性多肌痛的发病率和患病率:系统文献回顾。
Semin Arthritis Rheum. 2020 Oct;50(5):1040-1048. doi: 10.1016/j.semarthrit.2020.07.005. Epub 2020 Jul 14.
3
Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature.风湿性多肌痛患者的抑郁与抑郁症状:已发表文献系统评价中出现的讨论要点、灰色地带及未满足需求
Reumatologia. 2020;58(6):381-389. doi: 10.5114/reum.2020.102003. Epub 2020 Dec 23.
4
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis.风湿性多肌痛/巨细胞动脉炎患者的抗线粒体抗体与原发性胆汁性胆管炎
Medicina (Kaunas). 2021 Apr 6;57(4):350. doi: 10.3390/medicina57040350.
5
Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries.孤立性风湿性多肌痛(PMR)患者发热与红细胞沉降率(ESR)及C反应蛋白(CRP)浓度的相关性:一项医院与院外本地登记处的回顾性比较研究
Life (Basel). 2022 Jun 30;12(7):985. doi: 10.3390/life12070985.
6
Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature.疑似风湿性多肌痛患者快速通道诊所的可行性与实用性:通过对已发表文献的叙述性综述制定工作时间表的要点
Reumatologia. 2021;59(5):323-329. doi: 10.5114/reum.2021.110600. Epub 2021 Nov 7.
7
Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.土耳其西北部的巨细胞动脉炎和风湿性多肌痛:临床特征和流行病学数据。
Clin Exp Rheumatol. 2009 Sep-Oct;27(5):830-3.
8
The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica.全科医生和院外公共风湿病专家在风湿性多肌痛患者诊断及随访中的作用
Reumatismo. 2018 Mar 27;70(1):44-50. doi: 10.4081/reumatismo.2018.1036.
9
Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.风湿性多肌痛(PMR)或巨细胞动脉炎(GCA)患者的严重感染:一项美国全国性时间趋势研究。
Clin Rheumatol. 2020 Nov;39(11):3427-3438. doi: 10.1007/s10067-020-05129-w. Epub 2020 May 12.
10
The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.西班牙西北部风湿性多肌痛的谱:一项为期10年的研究中的发病率及与复发相关变量的分析
J Rheumatol. 1999 Jun;26(6):1326-32.

引用本文的文献

1
When can calcium pyrophosphate deposition disease be considered a polymyalgia rheumatica mimicking disease?焦磷酸钙沉积病何时可被视为一种类风湿性多肌痛样疾病?
Reumatologia. 2025 Jun 20;63(3):182-190. doi: 10.5114/reum/200191. eCollection 2025.
2
Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case Reports.接受纳武单抗和派姆单抗治疗的癌症患者中的风湿性多肌痛(PMR)和类风湿性多肌痛(PMR样)表现:通过对已发表病例报告的系统评价确定的方法学模糊点
Med Sci (Basel). 2025 Apr 1;13(2):34. doi: 10.3390/medsci13020034.
3
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature.感染因子与风湿性多肌痛:对已发表文献的叙述性综述中出现的关键讨论要点
Reumatologia. 2024;62(5):360-367. doi: 10.5114/reum/194687. Epub 2024 Nov 6.
4
Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic.一个专门的多肌痛快速诊疗门诊的真实世界疗效
Rheumatology (Oxford). 2025 May 1;64(5):3006-3011. doi: 10.1093/rheumatology/keae531.
5
Ibuprofen Would Be the First-Line Nonsteroidal Anti-inflammatory Drug for Polymyalgia Rheumatica: A Case Series of Five Patients.布洛芬将成为风湿性多肌痛的一线非甾体抗炎药:5例患者的病例系列
Cureus. 2024 Apr 22;16(4):e58778. doi: 10.7759/cureus.58778. eCollection 2024 Apr.
6
Serum metabolomic profiling identifies potential biomarkers in arthritis in older adults: an exploratory study.血清代谢组学分析鉴定老年关节炎潜在生物标志物:一项探索性研究。
Metabolomics. 2023 Apr 6;19(4):37. doi: 10.1007/s11306-023-02004-y.
7
Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries.孤立性风湿性多肌痛(PMR)患者发热与红细胞沉降率(ESR)及C反应蛋白(CRP)浓度的相关性:一项医院与院外本地登记处的回顾性比较研究
Life (Basel). 2022 Jun 30;12(7):985. doi: 10.3390/life12070985.
8
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature.风湿性多肌痛和多肌痛样综合征作为新冠病毒疫苗接种后的不良事件:来自已发表文献叙述性综述的工作笔记
Reumatologia. 2022;60(2):142-147. doi: 10.5114/reum.2022.115665. Epub 2022 May 18.
9
Polymyalgia Rheumatica.巨细胞动脉炎。
Dtsch Arztebl Int. 2022 Jun 17;119(24):411-417. doi: 10.3238/arztebl.m2022.0218.
10
The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios.肿瘤坏死因子α拮抗剂(抗TNF-α)在孤立性风湿性多肌痛(PMR)患者个性化治疗中的作用:过去及未来可能的情况。
J Pers Med. 2022 Feb 22;12(3):329. doi: 10.3390/jpm12030329.

本文引用的文献

1
Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis.诊断时红细胞沉降率和C反应蛋白浓度均正常的风湿性多肌痛。
Rheumatology (Oxford). 2019 May 1;58(5):921-923. doi: 10.1093/rheumatology/key431.
2
Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study.二十年来英国巨细胞动脉炎的发病率、患病率和治疗负担:一项基于人群的研究。
Ann Rheum Dis. 2018 Dec;77(12):1750-1756. doi: 10.1136/annrheumdis-2018-213883. Epub 2018 Oct 8.
3
Polymyalgia Rheumatica (PMR) with Normal Values of Both Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentration at the Time of Diagnosis in a Centenarian Man: A Case Report.百岁男性患者诊断时红细胞沉降率(ESR)和C反应蛋白(CRP)浓度均正常的风湿性多肌痛(PMR):一例报告
Diseases. 2018 Sep 20;6(4):84. doi: 10.3390/diseases6040084.
4
Diagnosis of polymyalgia rheumatica in primary health care: favoring and confounding factors - a cohort study.基层医疗中风湿性多肌痛的诊断:促进因素和混杂因素——一项队列研究
Reumatologia. 2018;56(3):131-139. doi: 10.5114/reum.2018.76900. Epub 2018 Jun 30.
5
Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis: a four-point guidance.诊断时红细胞沉降率和C反应蛋白浓度均正常的风湿性多肌痛:四点指南
Reumatologia. 2018;56(1):1-2. doi: 10.5114/reum.2018.74740. Epub 2018 Feb 28.
6
The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica.全科医生和院外公共风湿病专家在风湿性多肌痛患者诊断及随访中的作用
Reumatismo. 2018 Mar 27;70(1):44-50. doi: 10.4081/reumatismo.2018.1036.
7
The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome.风湿性多肌痛作为副肿瘤综合征的真实证据。
Reumatismo. 2018 Mar 27;70(1):23-34. doi: 10.4081/reumatismo.2018.1031.
8
Pathogenesis of polymyalgia rheumatica.风湿性多肌痛的发病机制。
Reumatismo. 2018 Mar 27;70(1):10-17. doi: 10.4081/reumatismo.2018.1048.
9
Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine.红细胞沉降率和C反应蛋白检测及其在临床医学中的相关性。
WMJ. 2016 Dec;115(6):317-21.
10
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study.意大利中部内陆地区类风湿关节炎、银屑病关节炎和风湿性多肌痛的发病率:CAMPO-RHE研究结果
Postgrad Med. 2018 Jan;130(1):137-141. doi: 10.1080/00325481.2018.1399774. Epub 2017 Nov 3.

风湿性多肌痛(PMR)的发病率和患病率:流行病学背景的重要性。

Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. .

作者信息

Manzo Ciro

机构信息

Rheumatology Outpatient Clinic, Poliambulatorio "Mariano Lauro", Sant'Agnello-Distretto Sanitario 59 (Penisola Sorrentina), ASL Napoli 3 sud, 80065 Sant'Agnello, Naples, Italy.

出版信息

Med Sci (Basel). 2019 Aug 30;7(9):92. doi: 10.3390/medsci7090092.

DOI:10.3390/medsci7090092
PMID:31480261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6780278/
Abstract

OBJECTIVES

to evaluate incidence and prevalence rates of polymyalgia rheumatica (PMR) in Italy, depending on the epidemiological methodology used from time to time.

MATERIALS AND METHODS

A comprehensive literature search in MEDLINE and EMBASE was carried out. The following search terms were used: polymyalgia rheumatica, incidence, prevalence, epidemiology, general practitioner, family medicine, Italy. A search was also carried out in Google scholar using the search phrase: epidemiology of polymyalgia rheumatica in Italy. The period considered was between 1970 and March 2019. All articles containing data on incidence and prevalence of PMR in Italy were read in full. Reviews and non-original manuscripts were excluded as well as all the studies containing incidence and prevalence rates of giant cell arteritis (GCA), unless clearly distinct from data related to patients with PMR alone (isolated and pure PMR).

RESULTS

Five articles corresponded to inclusion and exclusion criteria. Two articles were excluded as they were review articles, and three articles were excluded because there were not clear data on incidence and prevalence rates of isolated PMR. Three articles reported data on the annual incidence of PMR (two of them published by the same group of investigators); two articles reported prevalence data. In one article, both incidence and prevalence were calculated. The annual rate of incidence of PMR was between 0.12 and 2.3 cases/1000 inhabitants aged over 50 years. In the two studies publishing prevalence data, they varied from 0.37% to 0.62%. The differences in incidence and prevalence rates were related to several factors such as the different set of diagnostic criteria used for identifying patients or the diagnostic difficulty for patients with atypical presentations, specifically those without raised erythrocyte sedimentation rate (ESR). In the study with higher annual rate of incidence and higher prevalence of PMR, the collaboration between general practitioner (GP) and the out-of-hospital public rheumatologist resulted in significantly different data than in the other studies. All the five articles presented data from monocentric cohorts.

CONCLUSION

Very few Italian studies addressed the epidemiology of PMR. The contribution of a specific professional figure represented by the out-of-hospital public rheumatologist, present in the Italian National Health System and absent in other countries, can make the Italian experience unique in its kind.

摘要

目的

根据不同时期使用的流行病学方法,评估意大利风湿性多肌痛(PMR)的发病率和患病率。

材料与方法

在MEDLINE和EMBASE中进行全面的文献检索。使用了以下检索词:风湿性多肌痛、发病率、患病率、流行病学、全科医生、家庭医学、意大利。还在谷歌学术中使用搜索短语“意大利风湿性多肌痛的流行病学”进行了搜索。所考虑的时间段为1970年至2019年3月。阅读了所有包含意大利PMR发病率和患病率数据的文章。排除综述和非原创手稿,以及所有包含巨细胞动脉炎(GCA)发病率和患病率的研究,除非与仅患有PMR的患者(孤立性和单纯性PMR)的数据明显不同。

结果

五篇文章符合纳入和排除标准。两篇文章因是综述文章而被排除,三篇文章因没有关于孤立性PMR发病率和患病率的明确数据而被排除。三篇文章报告了PMR的年发病率数据(其中两篇由同一组研究人员发表);两篇文章报告了患病率数据。在一篇文章中,计算了发病率和患病率。PMR的年发病率在每1000名50岁以上居民中为0.12至2.3例。在两项公布患病率数据的研究中,患病率在0.37%至0.62%之间。发病率和患病率的差异与几个因素有关,如用于识别患者的不同诊断标准集,或非典型表现患者的诊断困难,特别是那些红细胞沉降率(ESR)未升高的患者。在PMR年发病率和患病率较高的研究中,全科医生(GP)与院外公共风湿病学家之间的合作产生的数据与其他研究有显著差异。所有五篇文章均提供了单中心队列的数据。

结论

很少有意大利研究涉及PMR的流行病学。意大利国家卫生系统中存在而其他国家没有的由院外公共风湿病学家代表的特定专业人员的贡献,可能使意大利的经验独具特色。